Welcome Glen, your right on the money here IMO...no pump or dump...great company..soon to be uplisted. We were all waiting long here..hopefully soon to be rewarded by the actions the company takes...claims are outta the way...i only see a bright future here...and the rest of the boys will agree with that i bet !! :-) Shares are VERY cheap at these levels....damn lowfloater buybacks in the making...new drugssoon selling......
Hello Glen, welcome on board. Maybe I should start with a short summary of what I think are the hightlights on GNPH:
Outlook for 2009 (FY ends June 30th): revenues approx 130 million, income 40 milion. Uplisting in the making, share buyback program ($2 million) has been announced, not yet active, seems to be a problem with transfering cash out of PRC. Three new drugs should be announced soon. Recent Hongrui acquisition has added 20+ new drugs/traditional chinese medicines. Shares outstanding approx. 10 million.
Possible negatives: see question abh3vt asked earlier. It has to do with a financing deal from may 2008, I think.